Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Solventum Corporation (SOLV)

Solventum Corporation (SOLV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,817,661
  • Shares Outstanding, K 173,448
  • Annual Sales, $ 8,254 M
  • Annual Income, $ 478,000 K
  • EBIT $ 2,192 M
  • EBITDA $ 2,747 M
  • 60-Month Beta 0.26
  • Price/Sales 1.79
  • Price/Cash Flow 8.58
  • Price/Book 2.96

Options Overview Details

View History
  • Implied Volatility 27.22% (+1.45%)
  • Historical Volatility 32.32%
  • IV Percentile 6%
  • IV Rank 8.13%
  • IV High 62.22% on 04/10/25
  • IV Low 24.12% on 11/26/25
  • Expected Move (DTE 10) 3.13 (3.79%)
  • Put/Call Vol Ratio 1.48
  • Today's Volume 124
  • Volume Avg (30-Day) 492
  • Put/Call OI Ratio 0.69
  • Today's Open Interest 14,151
  • Open Int (30-Day) 11,492
  • Expected Range 79.47 to 85.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.50
  • Number of Estimates 4
  • High Estimate 1.51
  • Low Estimate 1.49
  • Prior Year 1.41
  • Growth Rate Est. (year over year) +6.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
70.06 +17.90%
on 11/10/25
88.20 -6.35%
on 12/02/25
+11.08 (+15.49%)
since 11/07/25
3-Month
66.11 +24.94%
on 11/06/25
88.20 -6.35%
on 12/02/25
+8.00 (+10.72%)
since 09/08/25
52-Week
60.70 +36.08%
on 04/09/25
88.20 -6.35%
on 12/02/25
+12.64 (+18.07%)
since 12/06/24

Most Recent Stories

More News
3 Value Stocks with Open Questions

3 Value Stocks with Open Questions

SOLV : 82.60 (-3.31%)
CAG : 17.11 (+0.35%)
MAN : 27.77 (-0.43%)
1 Mid-Cap Stock on Our Buy List and 2 We Question

1 Mid-Cap Stock on Our Buy List and 2 We Question

SOLV : 82.60 (-3.31%)
AVY : 175.31 (-2.24%)
NXT : 89.70 (-0.98%)
1 Unpopular Stock That Should Get More Attention and 2 We Ignore

1 Unpopular Stock That Should Get More Attention and 2 We Ignore

SOLV : 82.60 (-3.31%)
CL : 76.11 (-2.51%)
IVZ : 25.81 (-1.64%)
Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity

Check out these three stocks that are up more than 20% in 2025 and just increased their buyback capacity. One stock experiencing strong growth stands out.

SOLV : 82.60 (-3.31%)
SE : 128.28 (-4.26%)
AVGO : 401.10 (+2.78%)
KEYS : 209.62 (-0.41%)
Is Becton, Dickinson and Company Stock Underperforming the Nasdaq?

Becton, Dickinson and Company has notably underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

SOLV : 82.60 (-3.31%)
$NASX : 23,545.90 (-0.14%)
BDX : 189.50 (-2.30%)
Solventum to Participate in the 2025 Piper Sandler Healthcare Conference

ST. PAUL, Minn. , Nov. 25, 2025 /PRNewswire/ -- Solventum  (NYSE: SOLV) announced today that management will participate in a fireside chat at the Piper Sandler Healthcare Conference on Tuesday,...

SOLV : 82.60 (-3.31%)
Teleflex, Solventum, Haemonetics, Centene, and Molina Healthcare Shares Skyrocket, What You Need To Know

Teleflex, Solventum, Haemonetics, Centene, and Molina Healthcare Shares Skyrocket, What You Need To Know

SOLV : 82.60 (-3.31%)
TFX : 119.82 (-0.56%)
MOH : 155.51 (+2.40%)
CNC : 37.88 (-1.20%)
HAE : 83.21 (-0.87%)
Stocks Reverse Sharply Lower as Tech Stocks Get Crushed

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed down by -1.56%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.84%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -2.38%....

MSTR : 183.69 (+2.63%)
SOLV : 82.60 (-3.31%)
GOOGL : 313.72 (-2.35%)
AMAT : 268.16 (+0.06%)
AAPL : 277.89 (-0.32%)
NDAQ : 89.80 (-0.47%)
PACS : 30.75 (-0.03%)
GLXY : 26.09 (+2.27%)
DDOG : 154.28 (+1.90%)
J : 140.06 (-0.11%)
$IUXX : 25,627.95 (-0.25%)
BBWI : 19.65 (+4.35%)
Solventum Announces Agreement to Acquire Acera Surgical

ST. PAUL, Minn. , Nov. 20, 2025 /PRNewswire/ -- Solventum  (NYSE: SOLV) announced today it has entered into a definitive agreement to acquire Acera Surgical (Acera), a privately held...

SOLV : 82.60 (-3.31%)
Solventum Announces $1 Billion Share Repurchase Program

ST. PAUL, Minn. , Nov. 20, 2025 /PRNewswire/ -- Solventum  (NYSE: SOLV) announced today its Board of Directors has approved a share repurchase program, which authorizes the Company to...

SOLV : 82.60 (-3.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 70%. The market has dropped from overbought territory. Beware of a potential mean reversion.

See More Share

Business Summary

Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn.

See More

Key Turning Points

3rd Resistance Point 87.34
2nd Resistance Point 86.33
1st Resistance Point 84.47
Last Price 82.60
1st Support Level 81.60
2nd Support Level 80.59
3rd Support Level 78.73

See More

52-Week High 88.20
Last Price 82.60
Fibonacci 61.8% 77.69
Fibonacci 50% 74.45
Fibonacci 38.2% 71.20
52-Week Low 60.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar